BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30710426)

  • 21. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
    Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
    Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    Anderson O; Guttilla Reed IK
    PLoS One; 2020; 15(5):e0233187. PubMed ID: 32396572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
    Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis.
    Mansoori B; Silvestris N; Mohammadi A; Khaze V; Baghbani E; Mokhtarzadeh A; Shanehbandi D; Derakhshani A; Duijf PHG; Baradaran B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33673143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
    Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals.
    Liu J; Shen JX; He D; Zhang GJ
    Mol Imaging Biol; 2018 Oct; 20(5):761-770. PubMed ID: 29532351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis.
    Avtanski DB; Nagalingam A; Tomaszewski JE; Risbood P; Difillippantonio MJ; Saxena NK; Malhotra SV; Sharma D
    Mol Oncol; 2016 Aug; 10(7):1118-32. PubMed ID: 27259808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
    Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
    Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
    Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
    Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.
    Liu Y; Li H; Feng J; Cui X; Huang W; Li Y; Su F; Liu Q; Zhu J; Lv X; Chen J; Huang D; Yu F
    PLoS One; 2013; 8(12):e83083. PubMed ID: 24349438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.